Insider · CIK 0001437782
Joseph Oliveto
Files at MIST (Milestone Pharmaceuticals Inc.). First filing Jan 9, 2026, latest Apr 20, 2026.
In brief
Joseph Oliveto files SEC Form 4 as CEO, president and director at MIST (Milestone Pharmaceuticals Inc.). Since Jan 9, 2026, Joseph Oliveto has reported 0 open-market buys worth $0 and 3 open-market sells worth $556k, the latest filed on Apr 20, 2026.
A track record needs three past buys with six months of prices behind them; Joseph Oliveto has 0, so none is measured yet.
The newest scored trade: sold $82k of MIST on Apr 16, 2026, filed Apr 20, 2026, scored 14 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $556k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MIST: Milestone Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 14Weak | Milestone Pharmaceuticals Inc. | $82k 36,500 shares | -8% | +156% from low-29% from high | |
| 51Moderate | Milestone Pharmaceuticals Inc. | $375k 167,577 shares | -29% | - | |
| 20Weak | Milestone Pharmaceuticals Inc. | $98k 43,500 shares | -13% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 16, 2026 | MIST Milestone Pharmaceuticals Inc. | 36,500 0.03% of outstanding | $80k | Apr 16, 2026 | none |
| Jan 8, 2026 | MIST MILESTONE PHARMACEUTICALS INC | 79,500 0.09% of outstanding | $171k | Jan 8, 2026 | $1,125 |
| Jan 7, 2026 | MIST Milestone Pharmaceuticals Inc. | 500 0.00% of outstanding | $1,025 | Jan 7, 2026 | none |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | MIST Milestone Pharmaceuticals Inc. | SOpen-market sale Common Shares10b5-1 | -36,500 | $2.26 | $82k | 446,244 | Apr 20, 2026 |
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +679,000 | $0.00 | $0 | 679,000 | Feb 5, 2026 |
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +679,000 | $0.00 | $0 | 679,000 | Feb 4, 2026 |
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Restricted Stock Unitderivative | +453,000 | $0.00 | $0 | 453,000 | Feb 4, 2026 |
| Dec 12, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Common Shares | +280,000 | - | - | 583,721 | Jan 28, 2026 |
| Dec 15, 2025 | MIST Milestone Pharmaceuticals Inc. | SOpen-market sale Common Shares | -133,054 | $2.32 | $309k | 450,667 | Jan 28, 2026 |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc. | MOption exercise Common Shares | +66,600 | - | - | 517,267 | Jan 28, 2026 |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc. | SOpen-market sale Common Shares | -34,523 | $1.93 | $67k | 482,744 | Jan 28, 2026 |
| Dec 12, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +280,000 | $0.00 | $0 | 280,000 | Jan 28, 2026 |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc. | MOption exercise Restricted Stock Unitsderivative | -66,600 | $0.00 | $0 | 199,800 | Jan 28, 2026 |
| Jan 7, 2026 | MIST Milestone Pharmaceuticals Inc. | SOpen-market sale Common Shares10b5-1 | -500 | $2.25 | $1,125 | 346,721 | Jan 9, 2026 |
| Jan 8, 2026 | MIST Milestone Pharmaceuticals Inc. | SOpen-market sale Common Shares10b5-1 | -43,000 | $2.25 | $97k | 303,721 | Jan 9, 2026 |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Common Shares | +66,666 | - | - | 347,221 | Jul 15, 2025 |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Series A Common Warrants (right to buy)derivative | +66,666 | - | - | 66,666 | Jul 15, 2025 |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Series B Common Warrants (right to buy)derivative | +66,666 | - | - | 66,666 | Jul 15, 2025 |
Questions about Joseph Oliveto
Answered from the filings on this page, as of the latest one.
Is Joseph Oliveto buying or selling?
In the last 12 months Joseph Oliveto reported 0 open-market buys worth $0 and 3 open-market sells worth $556k on SEC Form 4; the latest was sold $82k of MIST on Apr 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Joseph Oliveto's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph Oliveto has 0.
Where does Joseph Oliveto file Form 4?
Joseph Oliveto has filed Form 4 at MIST (Milestone Pharmaceuticals Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.